A large dimeric glycoprotein (440-500 kDa) of the extracellular matrix that serves as molecular scaffolding, binding simultaneously to integrins, collagen, fibrin, and heparin through distinct domains. Fibronectin exists in soluble plasma form (synthesized by hepatocytes) and insoluble cellular form (assembled by Fibroblasts and other cells), orchestrating cell adhesion, cell migration, wound healing, and embryonic development through integrin-mediated signaling.
Think of fibronectin as the steel rebar framework in a construction site — but one that also gives instructions to the workers. When a wound opens (the construction site), fibroblasts pour out soluble fibronectin dimers like liquid concrete mix. These dimers don't just float around — cells grab them via integrin "hands" (particularly the α5β1 integrin) and physically pull them into fibrillar cables, like workers stretching and weaving rebar into place. Once assembled, this fibronectin scaffolding does double duty: it provides physical tracks for cells to crawl along (imagine railway lines guiding repair crews to the damage site) AND it sends "start working" signals into those cells through the same integrin connections. The fibronectin grid connects to collagen pillars at specific docking sites, creating a provisional matrix — a temporary construction scaffold that holds everything in place while the permanent structure (mature collagen) is built. When remodeling begins, Matrix metalloproteinases (MMPs) arrive like demolition crews with bolt cutters, snipping the fibronectin cables at precise points to allow tissue reorganization. If the demolition crew never shows up or works too slowly, you get excessive fibronectin accumulation — the construction site becomes permanently cluttered with scaffolding (Fibrosis).
¶ Secretion and Assembly
- Fibroblasts, endothelial cells, and other mesenchymal cells synthesize fibronectin as a soluble dimer (two 250 kDa monomers linked by disulfide bonds at C-terminus)
- Plasma fibronectin is produced by hepatocytes and circulates at 300-400 μg/mL as an acute phase reactant
- Cellular fibronectin contains extra domains (ED-A, ED-B) via alternative splicing, absent in plasma form
¶ Domain Structure and Binding Partners
Each fibronectin monomer contains modular binding domains:
- Type I repeats: bind fibrin, heparin, bacterial adhesins
- Type II repeats: bind collagen and gelatin
- Type III repeats: contain RGD sequence (Arg-Gly-Asp) recognized by integrins (especially α5β1, αvβ3, αIIbβ3)
- Heparin-binding domain: binds heparan sulfate proteoglycans and growth factors
- Cell-binding domain: contains synergy site working with RGD for integrin activation
graph TD
A[Soluble fibronectin dimer secreted] --> B["Integrin α5β1 binds RGD + synergy site"]
B --> C[Integrin clustering and signaling]
C --> D[Actin cytoskeleton contraction via RhoA]
D --> E[Mechanical stretching of fibronectin dimer]
E --> F[Cryptic sites exposed on stretched fibronectin]
F --> G[Dimer-dimer interactions form fibrils]
G --> H[Insoluble fibronectin matrix assembled]
H --> I[Cross-linking by transglutaminase]
C --> J[FAK phosphorylation]
J --> K[ERK/MAPK activation]
K --> L["Gene transcription: collagen, more fibronectin"]
Fibronectin binding to α5β1 integrin → integrin clustering → recruitment of talin and paxillin to cytoplasmic tail → focal adhesion kinase (FAK) autophosphorylation at Tyr397 → Src family kinase recruitment → ERK1/2 and AKT pathway activation → transcription of genes for proliferation, migration, survival, and collagen synthesis
During wound healing:
- Days 0-3: Plasma fibronectin deposited in provisional matrix with fibrin clot
- Days 2-6: Peak cellular fibronectin production by migrating Fibroblasts (2-3x baseline)
- Day 3-4: Fibronectin provides adhesive tracks for keratinocyte migration across wound bed
- Days 5-7: Fibronectin guides endothelial cell migration for angiogenesis
- Weeks 2-4: Matrix metalloproteinases (MMPs) (especially MMP-2, MMP-9) cleave fibronectin as collagen I and III replace provisional matrix
- MMP-2 and MMP-9 cleave at specific sites in type III repeats
- Fragments can act as matrikines (bioactive signals)
- 29-kDa N-terminal fragment has chemotactic activity
- 120-kDa fragment containing cell-binding domain modulates cell behavior
Fibronectin is the early-response molecule that determines whether healing proceeds normally or stalls. In diabetic wounds, high glucose inhibits fibronectin assembly through AGE-mediated crosslinking and reduced integrin expression — the scaffolding never forms properly, leaving cells without migration tracks. Plasma fibronectin levels <200 μg/mL during acute inflammation (sepsis, trauma, surgery) predict impaired healing and increased infection risk, as opsonization and immune cell recruitment depend on fibronectin's opsonin function.
From a 5 plus 2 metamodel perspective, fibronectin sits at the intersection of Metamodel 1 (energy distribution — cells must invest ATP to pull fibronectin into fibrils) and Metamodel 3 (barrier function — fibronectin organizes basement membrane architecture). The selfish immune system uses fibronectin as a damage sensor: fibronectin fragments generated by MMP cleavage act as DAMPs, signaling continued tissue disruption.
Excessive fibronectin deposition occurs when the remodeling phase fails:
- TGF-beta signaling (via Smad3) drives continuous fibronectin synthesis by myofibroblasts
- In Idiopathic pulmonary fibrosis, ED-A fibronectin (cellular isoform) persists instead of being replaced by collagen
- Hepatic stellate cells in liver fibrosis produce 5-10x normal fibronectin levels
- Intervention target: blocking ED-A domain or inhibiting TGF-β/Smad3 pathway
Plasma fibronectin decreases during acute phase response (paradoxical for an acute phase protein):
- Healthy baseline: 300-400 μg/mL
- Acute inflammation/sepsis: <200 μg/mL (consumed in tissue repair and opsonization)
- Recovery marker: return to >250 μg/mL indicates resolution phase
- Combination with CRP and IL-6: high CRP + high IL-6 + low fibronectin = severe systemic inflammation
Tumor cells exploit fibronectin highways:
- Breast and melanoma cells upregulate α5β1 integrin to bind fibronectin tracks
- Fibronectin assembly in tumor stroma creates migration routes
- Oncofetal fibronectin (ED-B containing) marks angiogenic vessels in tumors
- Therapeutic strategy: integrin-blocking peptides or antibodies against ED-B fibronectin
Support fibronectin function:
- Vitamin C (cofactor for collagen synthesis that pairs with fibronectin)
- Zinc (required for MMP regulation and proper matrix turnover)
- Curcumin (modulates TGF-β signaling to prevent excessive deposition)
- Mechanical loading (fibroblasts require tension to assemble fibronectin — hence movement post-injury)
Clinical monitoring:
- Plasma fibronectin <200 μg/mL → consider L-Arginine (NO production supports integrin clustering), Omega-3 fatty acids (resolve inflammation to restore synthesis)
- Non-healing wounds → assess glucose control (HbA1c target <7%), zinc status, vitamin C intake
- Fibronectin molecular weight: 440-500 kDa as dimer (each monomer ~250 kDa)
- Plasma concentration: 300-400 μg/mL in health; <200 μg/mL in sepsis/acute inflammation
- Peak production during wound healing: days 2-4 (coinciding with fibroblast proliferation phase)
- Primary integrin receptor: α5β1 (also binds αvβ3, α4β1, αIIbβ3 depending on cell type)
- Assembly requires: cell-generated tension (RhoA-mediated actin contraction) + integrin clustering
- ED-A and ED-B domains: present only in cellular fibronectin, absent in plasma form
- MMP-2 and MMP-9 are primary degradation enzymes during matrix remodeling
- Half-life in plasma: ~24 hours; tissue-bound fibronectin persists weeks to months
- Fibronectin fragments (29 kDa, 120 kDa) act as chemotactic factors and DAMPs
- Fibrosis marker: persistence of ED-A fibronectin >2 weeks post-injury indicates pathological remodeling
- extracellular matrix — fibronectin is one of three major ECM glycoproteins (with laminin and collagen)
- Fibroblasts — primary producers of cellular fibronectin during wound repair and fibrosis
- wound healing — provides provisional matrix in inflammatory phase (days 0-6) as scaffold for cell migration
- collagen — fibronectin binds collagen I, II, III via type II repeats, organizing ECM architecture
- integrins — α5β1 integrin is the canonical fibronectin receptor mediating assembly and signaling
- cell adhesion — RGD sequence in type III repeat enables integrin-mediated cell attachment
- cell migration — fibronectin fibrils serve as adhesive tracks for keratinocytes, fibroblasts, immune cells
- angiogenesis — endothelial cells use fibronectin tracks for vessel sprouting during neovascularization
- Fibrosis — excessive fibronectin (especially ED-A isoform) accumulation drives pathological scarring
- Matrix metalloproteinases (MMPs) — MMP-2 and MMP-9 cleave fibronectin during ECM remodeling
- inflammation — plasma fibronectin decreases as acute phase reactant (consumed in tissue repair)
- TGF-beta — TGF-β/Smad3 signaling drives continuous fibronectin synthesis by myofibroblasts in fibrosis
- DAMPs — fibronectin fragments from MMP cleavage act as damage signals activating TLR4
- basement membrane — fibronectin cross-links collagen IV and laminin in basement membrane assembly
- Osteoblasts — use fibronectin-integrin signaling for bone matrix organization
- AGEs — advanced glycation end-products crosslink fibronectin in diabetes, impairing function
- RhoA — GTPase mediating actin contraction required for mechanical fibronectin assembly
- FAK — focal adhesion kinase phosphorylated downstream of fibronectin-integrin binding
- Vitamin C — ascorbate required for collagen hydroxylation that pairs with fibronectin in mature ECM
- Zinc — cofactor for MMPs that regulate fibronectin turnover during remodeling
- ERK — ERK1/2 MAPK activated by fibronectin-integrin signaling promotes proliferation genes
- Endothelial dysfunction — loss of vascular fibronectin impairs endothelial barrier integrity
- Curcumin — modulates TGF-β pathway to reduce excessive fibronectin in fibrotic conditions
- Connective Tissue Walkthrough: Fibronectin functions as molecular glue cross-linking ECM macromolecules and enabling cell adhesion to basement membrane
- Wound Healing Walkthrough: Fibronectin peaks days 2-3 in inflammatory phase, providing initial scaffold for cell adhesion and migration